Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension

Parkinsonism Relat Disord. 2022 Jun:99:62-64. doi: 10.1016/j.parkreldis.2022.05.002. Epub 2022 May 13.

Abstract

We evaluate the effect of droxidopa on gait and balance measures in nine patients with Parkinson's disease and neurogenic orthostatic hypotension. Computerized gait/balance analysis showed a significant effect of droxidopa in reducing postural sway. Future studies may determine if such effect translates into improvement in postural reflexes and falls.

Keywords: Droxidopa; Orthostatic hypotension; Parkinson disease; Postural sway; Wearables.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Droxidopa* / therapeutic use
  • Humans
  • Hypotension, Orthostatic* / drug therapy
  • Hypotension, Orthostatic* / etiology
  • Parkinson Disease* / complications
  • Parkinson Disease* / drug therapy
  • Reflex

Substances

  • Antiparkinson Agents
  • Droxidopa